Accuracy of dynamic navigation in implant surgery: A systematic review and meta‐analysis

Author(s):  
Shi‐Min Wei ◽  
Yu Zhu ◽  
Jian‐Xu Wei ◽  
Chu‐Nan Zhang ◽  
Jun‐Yu Shi ◽  
...  
2011 ◽  
Vol 20 (10) ◽  
pp. 1596-1606 ◽  
Author(s):  
Wouter A. Moojen ◽  
Mark P. Arts ◽  
Ronald H. M. A. Bartels ◽  
Wilco C. H. Jacobs ◽  
Wilco C. Peul

2019 ◽  
Vol 30 (S19) ◽  
pp. 397-397
Author(s):  
Pierfrancesco Filetici ◽  
Giuseppe Troiano ◽  
Luigi Laino ◽  
Francesca Longo ◽  
Ilaria D'Onofrio ◽  
...  

2018 ◽  
Vol 29 (S16) ◽  
pp. 416-435 ◽  
Author(s):  
Ali Tahmaseb ◽  
Vivian Wu ◽  
Daniel Wismeijer ◽  
Wim Coucke ◽  
Christopher Evans

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Basim E. S. Dawoud ◽  
Samuel Kent ◽  
Oliver Tabbenor ◽  
Pynadath George ◽  
Jagtar Dhanda

Abstract Background Dental implant placement is safe and predictable, yet optimal management of anticoagulated patients remains controversial. Whilst cessation of anticoagulation pre-operatively should decrease risks of bleeding, risk of thrombosis increases. We aim to define risk of bleeding in patients on oral anticoagulation who are undergoing dental implant placement, in order to establish best management. Methods This systematic review is registered with the National Institute for Health Research (NIHR) PROSPERO database (Registration No: CRD42021233929). We performed a systematic review as per Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidance. Studies were identified using an agreed search strategy within the OVID Gateway (this included Pubmed, MEDLINE, Cochrane Collaborative). Studies assessing bleeding complications in patients who were undergoing dental implant placement were selected. The primary outcome was bleeding events in anticoagulated patients undergoing dental implant placement. Secondary outcomes included any complication requiring further intervention. Results We identified 182 studies through screening, and after review of titles and abstracts reduced this to 8 studies. In these studies, 1467 participants received at least 2366 implants. Studies were analysed for quality using the ROBINS-I risk of bias tool. Four studies were retrospective case reviews, and four were prospective reviews, three of which also blinded the operator to anticoagulation status. There was significant heterogeneity between the included studies. Meta-analysis showed an increased risk of bleeding (RR, 2.30; 95% CI, 1.25-4.24 p = 0.37 I = 7%) when implants were placed in the presence of anticoagulation however these were not clinically significant haemorrhagic events. Conclusion The continuation of anticoagulants peri-operatively during dental implant surgery does increase the risk of clinically non-significant peri- and post-operative bleeding. Dental implant surgery encompasses a broad spectrum of procedures ranging from minor to more invasive surgery with simple local haemostatic measures mitigating the risk of bleeding. The decision to discontinue anticoagulants prior to dental implant surgery must consider patient and surgical factors with the clinician undertaking a risk-balance assessment.


2021 ◽  
Vol 36 (5) ◽  
pp. e121-e140
Author(s):  
Gerardo Pellegrino ◽  
Agnese Ferri ◽  
Massimo Del Fabbro ◽  
Carlo Prati ◽  
Maria Gandolfi ◽  
...  

PLoS ONE ◽  
2016 ◽  
Vol 11 (4) ◽  
pp. e0154082 ◽  
Author(s):  
Chia-Shu Lin ◽  
Shih-Yun Wu ◽  
Hsin-Yi Huang ◽  
Yu-Lin Lai

2021 ◽  
Vol 10 (5) ◽  
pp. 1118
Author(s):  
Huub Poelman ◽  
Jan Pals ◽  
Parinaz Rostamzad ◽  
Wichor Bramer ◽  
Roger Wolfs ◽  
...  

Background: To assess the efficacy of XEN-implant surgery in patients with glaucoma, and to perform a meta-analysis of previously published results and compare these to our data. Methods: Prospective case-control study, in which all eyes that underwent XEN-implant surgery were included from 2015 onwards. Sub-analyses were performed for eyes that underwent XEN-implant as standalone procedure and as cataract-combined procedure. To compare our results, a systematic review was performed using the Embase, PubMed, Web of Science, and Cochrane database. Meta-analyses were performed by combining data (intraocular pressure (IOP), IOP-lowering medication, and complications) from the retrieved studies. Results: A total of 221 eyes underwent XEN-implant surgery (124 standalone and 97 cataract-combined). The mean ± standard deviation IOP declined from 18.8 ± 6.5 to 13.5 ± 4.3 mmHg at the last follow-up (p < 0.001; 28.9%). Postoperative, no significant differences in IOP or IOP-lowering medication were found between patients with and without combined procedure. Secondary surgeries were performed in 20.8% of eyes, most of them (63.0%) within six months. A meta-analysis of 19 studies retrieved from the systematic review showed a two-years postoperative pooled mean (weighted mean difference) of 14.5 (7.3) mmHg and 1.0 (1.6) for IOP and IOP-lowering medications, respectively (compared to 13.5 (5.3) mmHg and 3.2 (2.4) in the current study). Conclusion: XEN-implant surgery was effective and safe in lowering IOP and the number of IOP-lowering medications. There were no differences between standalone and combined procedures.


Sign in / Sign up

Export Citation Format

Share Document